At #ASCO26, Dr Marchetti presented findings showing that short-term fasting improved chemotherapy response and prolonged progression-free survival in advanced #ovariancancer. ecancer.org/en/video/129...
New data in metastatic uveal #melanoma at #ASCO26 suggest that darovasertib + crizotinib may offer a new treatment option for patients with limited alternatives. Dr Orloff reviews findings showing improved PFS and response rates versus standard therapy. ecancer.org/en/video/129...